Kurzrock R - Search Results

1

The role of cytokines in cancer-related fatigue.

Kurzrock R. Kurzrock R. Cancer. 2001 Sep 15;92(6 Suppl):1684-8. doi: 10.1002/1097-0142(20010915)92:6+<1684::aid-cncr1497>3.0.co;2-z. Cancer. 2001. PMID: 11598887 Review.

2

Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.

Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Baiocchi G, et al. Among authors: kurzrock r. Cancer. 1991 Feb 15;67(4):990-6. doi: 10.1002/1097-0142(19910215)67:4<990::aid-cncr2820670422>3.0.co;2-8. Cancer. 1991. PMID: 1825026

3

Sweet syndrome in patients with solid tumors.

Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R. Cohen PR, et al. Among authors: kurzrock r. Cancer. 1993 Nov 1;72(9):2723-31. doi: 10.1002/1097-0142(19931101)72:9<2723::aid-cncr2820720933>3.0.co;2-f. Cancer. 1993. PMID: 8402496 Review.

4

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Kurzrock R, et al. Cancer Res. 1993 May 1;53(9):2118-22. Cancer Res. 1993. PMID: 8481913

5

Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.

Kellokumpu-Lehtinen P, Talpaz M, Harris D, Van Q, Kurzrock R, Estrov Z. Kellokumpu-Lehtinen P, et al. Among authors: kurzrock r. Int J Cancer. 1996 May 16;66(4):515-9. doi: 10.1002/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8635867

6

Cytokine deregulation in hematological malignancies: clinical and biological implications.

Kurzrock R. Kurzrock R. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2581-4. Clin Cancer Res. 1997. PMID: 9815659 Review.

7

Cytokine deregulation in cancer.

Kurzrock R. Kurzrock R. Biomed Pharmacother. 2001 Nov;55(9-10):543-7. doi: 10.1016/s0753-3322(01)00140-8. Biomed Pharmacother. 2001. PMID: 11769963 Review.

8

Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.

Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R. Wu HH, et al. Among authors: kurzrock r. Cancer. 2003 Dec 1;98(11):2410-9. doi: 10.1002/cncr.11810. Cancer. 2003. PMID: 14635076 Free article. Clinical Trial.

9

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.

Tsimberidou AM, Giles F, Romaguera J, Duvic M, Kurzrock R. Tsimberidou AM, et al. Among authors: kurzrock r. Cancer. 2004 Feb 1;100(3):574-80. doi: 10.1002/cncr.20009. Cancer. 2004. PMID: 14745875 Free article.

10

Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.

Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R. Li L, et al. Among authors: kurzrock r. Cancer. 2004 Nov 15;101(10):2351-62. doi: 10.1002/cncr.20605. Cancer. 2004. PMID: 15476283 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,019 results

Search Page

Filters